ArticleMolecular therapy. Methods & clinical development2024

CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model.

Nadia Amrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.